A Phase I Multicenter Study of the Safety, Tolerability, Viral Shedding Profile, and Immunogenicity of a Recombinant, Live, Attenuated Respiratory Syncytial Virus Subgroup A Strain, rA2cp NS2 in Adults, RSV-Seropositive 15 to 59 Month Old Children, and RSV-Susceptible Children (Seronegative 6 to 24 Month Old Children and Unscreened 4 to 5 Month Old Children) (D133-P7) Wyeth Lederle Vaccines

Status: Completed

Phase of Trial: Phase I

Latest Information Update: 26 Aug 2013

Price :

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com